Retraction: Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity (PLoS ONE (2013) 8:2 (e51309) DOI: 10.1371/journal.pone.0051309);Curcumin Potentiates Rhabdomyosarcoma Radiosensitivity by Suppressing NF-κB Activity

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Orr, W Shannon ^a,b   Denbo, Jason W ^a,b   Saab, Karim R ^b   Ng, Catherine Y ^b   Wu, Jianrong ^b   Li, Kui ^a   Garner, Jo Meagan ^a   Morton, Christopher L ^b   Du, Ziyun ^a   Pfeffer, Lawrence M ^a   Davidoff, Andrew M ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P100;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL PROLIFERATION; CHEMORADIOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIOSENSITIVITY; RHABDOMYOSARCOMA; TUMOR CELL; TUMOR XENOGRAFT; UPREGULATION;

EID: 84873605819     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0222130     Document Type: Erratum

References (27)

1. Loeb DM, Thornton K, Shokek O (2008) Pediatric soft tissue sarcomas. Surg Clin North Am; 88: 615-27, vii.
2. Meza JL, Anderson J, Pappo AS, Meyer WH, (2006) Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. J Clin Oncol 24: 3844-51.
3. Raney RB, Maurer HM, Anderson JR, Andrassy RJ, Donaldson SS, Qualman SJ, et al. (2001) The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols. Sarcoma 5: 9-15.
4. Hancock SL, Tucker MA, Hoppe RT, (1993) Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270: 1949-55.
5. Hull MC, Morris CG, Pepine CJ, Mendenhall NP, (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA 290: 2831-7.
6. Meadows AT, D'Angio GJ, (1974) Late effects of cancer treatment: methods and techniques for detection. Semin Oncol 1: 87-90.
7. Meadows AT, Gordon J, Massari DJ, Littman P, Fergusson J, et al. (1981) Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet 2: 1015-8.
8. Meadows AT, (1986) Second malignant neoplasms in childhood cancer survivors. J Assoc Pediatr Oncol Nurses 6: 7-11.
9. Bonizzi G, Karin M, (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-8.
10. Gilmore TD, (2003) The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer. Cancer Treat Res 115: 241-65.
11. Pomerantz JL, Baltimore D, (2002) Two pathways to NF-kappaB. Mol Cell 10: 693-5.
12. Aggarwal BB, (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-8.
13. Kunnumakkara AB, Anand P, Aggarwal BB, (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269: 199-225.
14. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, et al. (2005) Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11: 7490-8.
15. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, (2006) Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69: 195-206.
16. Duarte VM, Han E, Veena MS, Salvado A, Suh JD, et al. (2010) Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKbeta protein of the NFkappaB pathway. Mol Cancer Ther 9: 2665-75.
17. Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, et al. (2008) Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clin Cancer Res 14: 2128-36.
18. Aravindan N, Veeraraghavan J, Madhusoodhanan R, Herman TS, Natarajan M, (2011) Curcumin regulates low-linear energy transfer gamma-radiation-induced NFkappaB-dependent telomerase activity in human neuroblastoma cells. Int J Radiat Oncol Biol Phys 79: 1206-15.
19. Sandur SK, Deorukhkar A, Pandey MK, Pabon AM, Shentu S, et al. (2009) Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. Int J Radiat Oncol Biol Phys 75: 534-42.
20. Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al. (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6: 10.
21. Li L, Braiteh FS, Kurzrock R, (2005) Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104: 1322-31.
22. Rosati SF, Williams RF, Nunnally LC, McGee MC, Sims TL, et al. (2008) IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression. Mol Cancer Ther 7: 3852-8.
23. Sims TL, McGee M, Williams RF, Myers AL, Tracey L, Hamner JB, et al. (2010) IFN-beta restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation. Mol Cancer Ther 9: 761-71.
24. Spurbeck WW, Ng CY, Strom TS, Vanin EF, Davidoff AM, (2002) Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. Blood 100: 3361-8.
25. Greco WR, Park HS, Rustum YM, (1990) Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res 50: 5318-27.
26. Machado SG, Robinson GA, (1994) A direct, general approach based on isobolograms for assessing the joint action of drugs in pre-clinical experiments. Stat Med 13: 2289-309.
27. Chang YH, Hsieh SL, Chen MC, Lin WW, (2002) Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation. Exp Cell Res 278: 166-74.